Heparin PF 4 Antibody Assay

The risk of Heparin Induced Thrombocytopenia (HIT) is greatly increased in patients with recent exposure to Heparin. HIT is often caused by platelet-activating antibodies, that recognize complexes of heparin/PF4. As a result, antibody detection is rapidly becoming a standard of care in hematology and cardiology. Currently available laboratory tests for HIT are classified as high complexity, take many hours to perform and often provide confirmation of HIT or HIT and Thrombosis (HITT) after the symptoms are seen in a patient. As a result, there is a need for an easily performed, rapid test that helps clinicians identify and treat patients at risk for HIT or Thrombosis.

Additional extensive literature available. CE, Health Canada licensed and FDA cleared. Please contact us for more information about pending regulatory status for individual countries.


Comments are closed.